Brain natriuretic peptide in primary pulmonary hypertension. Correlation with functional capacity and hemodynamic parameters;Niveles de péptido natriurético cerebral y su relación con capacidad funcional y hemodinamia pulmonar en pacientes con hipertensión pulmonar primaria

Revista Medica de Chile

Volumn 134, Issue 3, 2006, Pages 299-304

  Greig, Douglas ^a   Castro, Pablo ^a,b   Ferrada, Marcela ^a   Lim, Jongsung ^a   López, Cristián ^a   Braun, Sandra ^a   Córdova, Samuel ^a   Salazar, Margarita ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Hypertension, pulmonary; Natriuretic peptide, brain; Respiratory insufficiency

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ARTICLE; BLOOD; BLOOD PRESSURE; CASE CONTROL STUDY; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART OUTPUT; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PULMONARY HYPERTENSION; VASCULAR RESISTANCE; WALKING;

BIOLOGICAL MARKERS; BLOOD PRESSURE; CARDIAC OUTPUT; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; VASCULAR RESISTANCE; WALKING;

EID: 33646469841     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. FARBER HW, LOSCALZO J. Pulmonary Arterial Hypertension. N Engl J Med 2004; 351: 1655-65.
2. RUNO JR, LOYD JE. Primary pulmonary hypertension. Lancet 2003; 361: 1533-44.
3. MIYAMOTO S, NAGAYA N, SATOH T, KYOTANI S, SAKAMAKI F, FUJITA M ET AL. Clinical correlates and prognostic significance of six minutes walk test in patients with primary pulmonary hypertension. Comparison with cardiopulmonary exercise testing. Am J Respir Crit Care Med 2000; 161: 487-92.
4. SUN XG, HANSEN JE, OUDIZ RJ, WASSERMAN K. Exercise pathophysiology in patients with primary pulmonary hypertension. Circulation 2001; 104: 429-35.
5. RICH S ET AL. Executive summary from the World Heart Symposium on Primary Pulmonary Hypertension, Evian, France. 1998.
6. STEIN JHE, NEUMANN A, PRESTON LM, COSTANZO MR, PARRILLO JE, JOHNSON MR ET AL. Echocardiography for hemodynamic assessment of patients with advanced heart failure and potential heart transplant recipients. J Am Coll Cardiol 1997; 30: 1765-72.
7. ABBAS AE, FORTUIN FD, SCHILLER NB, APPLETON CP, MORENO CA, LESTER SJ. A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol 2003; 41: 1021-7.
8. NAGAYA N, PL NISHIKIMI T, OKANO Y, UEMATSU M, SATOH T, KYOTANI S ET AL. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998; 31: 202-8.
9. MUKOMAYA M. Plasma brain natriuretic peptide as a novel cardiac hormone in humans. Evidence of exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991; 87: 1402-12.
10. MCCULLOUGH PA, OMLAND T, MAISEL AS. B-type natriuretic peptides: a diagnostic breakthrough for clinicians. Rev Cardiovasc Med 2003; 4: 72-80.
11. MUELLER C, SCHOLER A, LAURLE-KILIAN K, MARTINA B, SCHINDLER C, BUSER P ET AL. Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea. N Engl J Med 2004; 350: 647-54.
12. THOMAS JW, LARSON MG, LEVI D, BENJAMIN EJ, LEIP EP, OMLAND T ET AL. Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death. N Engl J Med 2004; 350: 655-63.
13. DE LEMOS JA, MORROW DA, BENTLEY JH, OMLAND T, SABATINE MS, MCCABE CH ET AL. The Prognostic Value of B-Type Natriuretic Peptide in Patients with Acute Coronary Syndromes. N Engl J Med 2001; 345: 1014-21.
14. Manual de Ecocardiografía. Departamento de Ecocardiografía, Sociedad Chilena de Cardiología y Cirugía Cardiovascular. 2004.
15. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002; 166: 111-7.
16. KRUGER S, GRAF J, KUNZ D, STICKEL T, HANRATH P, JANSSENS U. Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol 2002; 40: 718-22.
17. NOOTENS M, KAUFMANN E, RECTOR T, TOHER C, JUDD D, FRANCIS GS ET AL. Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: relation to hemodynamic variables and endothelin levels. J Am Coll Cardiol 1995; 26: 1581-5.
18. NAGAYA N, NISHIKIMI T, UEMATSU M, SATOH T, KYOTANI S, SAKAMAKI F ET AL. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000; 102: 865-70.
19. HUMBERT M, SITBON O, SIMONNEAU G. Treatment of Pulmonary Arterial hypertension. N Engl J Med 2004; 351: 1425-36.